B. Millar

发表

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an ‘operational cure’?

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

S. Singhal, J. Mehta, D. Tait, 2000, The Lancet.

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

S. Singhal, J. Mehta, B. Sirohi, 2000, Bone Marrow Transplantation.

High‐dose chemotherapy and autologous bone marrow transplantation for myeloma

M. Gore, C. Viner, T. Mcelwain, 1989, European journal of haematology. Supplementum.

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation

A. Shankar, C. Pinkerton, K. Pritchard-Jones, 1997, British journal of haematology.

Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma

M. Gore, C. Viner, T. Mcelwain, 1990, British journal of haematology.

Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS‐3P cell separators for leukapheresis after high‐dose filgrastim in patients with hematologic malignancies

S. Singhal, J. Mehta, V. Shepherd, 1997, Journal of clinical apheresis.

Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisolone

D. Cunningham, J. Mansi, C. Viner, 1990, Hematological Oncology.

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.

S. Singhal, J. Mehta, N. Raje, 1997, British Journal of Cancer.

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

S. Singhal, J. Mehta, D. Cunningham, 1997, British journal of haematology.

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

S. Singhal, J. Mehta, M. Gore, 1997, Bone Marrow Transplantation.

High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results.

S. Singhal, J. Mehta, T. Min, 1996, Leukemia & lymphoma.

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

M. Gore, I. Judson, M. Slevin, 1989, The Lancet.

Peripheral blood stem cells Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?

S. Singhal, J. Treleaven, S. Goyal, 2002 .